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Abstract 12 
The combinatory use of high-intensity focused ultrasound (HIFU) and epirubicin (EPI)-13 
conjugated polymeric micellar nanoparticles (NC-6300) is thought to be a less invasive and more 14 
efficient method of cancer therapy. To investigate the mechanism underlying the combination effect, 15 
we examined the effect of trigger-pulsed HIFU (TP-HIFU) and NC-6300 from the perspective of 16 
reactive oxygen species (ROS) generation, which is considered the primary function of sonodynamic 17 
therapy (SDT), and changes in drug characteristics. TP-HIFU is an effective sequence for generating 18 
hydroxyl radicals to kill cancer cells. EPI was susceptible to degradation by TP-HIFU through the 19 
production of hydroxyl radicals. In contrast, EPI degradation of NC-6300 was suppressed by the 20 
hydrophilic shell of the micelles. NC-6300 also exhibited a sonosensitizer function, which promoted 21 
the generation of superoxide anions by TP-HIFU irradiation. The amount of ROS produced by TP-22 
HIFU reached a level that caused structural changes to the cellular membrane. In conclusion, drug-23 
conjugated micellar nanoparticles are more desirable for SDT because of accelerated ROS production 24 
and drug protection from ROS. Furthermore, a combination of NC-6300 and TP-HIFU is useful for 25 
minimally invasive cancer therapy with cooperative effects of HIFU-derived features, antitumor 26 
activity of EPI, and increased ROS generation to cause damage to cancer cells. 27 
Keywords: Sonodynamic therapy, High-intensity focused ultrasound, Reactive oxygen species, 28 
Triggered high-intensity focused ultrasound, Drug-Conjugated Polymeric Micelles   29 
1. Introduction 30 
  The application of ultrasound has greatly improved disease diagnosis and therapeutics in 31 
clinical practice. High-intensity focused ultrasound (HIFU) is an important method that causes a 32 
large temperature increase at the focal region, causing thermal ablation of tissue (Dubinsky et al., 33 
2008). HIFU is clinically employed for managing prostate cancer, hepatocellular carcinoma, uterine 34 
leiomyomas, and breast tumors (Copelan et al., 2015). Although ablation itself has large effects, the 35 
higher energy is associated with the risk of adverse effects like skin burns and the possibility of 36 
energy absorption in the muscles and bones in the body (Copelan et al., 2015). 37 
Sonodynamic therapy (SDT) is a combination treatment of ultrasound irradiation and 38 
sonosensitizer administration that shows potential as a minimally invasive treatment for cancer 39 
(Lafond et al., 2018). The sonosensitizer originated from the photosensitizer used for photodynamic 40 
therapy and displayed similar functions when combined with ultrasound instead of light (Tachibana 41 
et al., 2008; Umemura et al., 1993).  Several sonosensitizers have been reported, including the 42 
porphyrin complex, rose Bengal, titanium oxide, gold nanoparticles, and anticancer drugs like 43 
anthracyclines (Costley et al., 2015).  44 
Although the mechanism of SDT is unclear, it is probably based on the activation of a 45 
sonosensitizer via acoustic cavitation and generation of reactive oxygen species (ROS) (Riesz et al., 46 
1985). In photodynamic therapy, the trigger for singlet oxygen generation is the light-based 47 
excitation of the photo-sensitizer. In contrast, SDT is thought to be more complex because of the 48 
non-direct reaction between the sonosensitizer and ultrasound. Some intermediate steps are related to 49 
acoustic cavitation between the initiation of ultrasound irradiation and final ROS generation. 50 
Acoustic cavitation involves gas bubbles in the medium generated via ultrasound irradiation. Inertial 51 
cavitation refers to the rapid growth and collapse of bubbles, and stable cavitation refers to the 52 
sustained oscillatory motion of bubbles (Mitragotri, 2005). A previous study suggested two major 53 
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mechanisms of ROS generation via acoustic cavitation, referred to as “sono-luminescense” and 54 
“pyrolysis” (Misik et al., 2000; Kuroki et al., 2007).  55 
Several ROS are reportedly involved in SDT. Hydroxyl radicals are well-known ultrasound-56 
related ROS (Misik et al., 2000). The superoxide anion is generated from doxorubicin, a widely used 57 
anticancer agent (Yumita et al., 1989). Singlet oxygen is generated via SDT and photodynamic 58 
therapy (Canavese et al., 2018). 59 
Numerous challenges exist regarding nanoparticle preparation via sonosensitizers (Serpe et 60 
al., 2012). Some sono-sensitizers are highly hydrophobic and show a disadvantageous distribution in 61 
the body. To overcome these limitations, an approach for forming nanoparticles, which are useful as 62 
drug delivery systems and include liposomes, polymers, and poly(lactic-co-glycolic acid), were 63 
reported including microbubble encapsulation (Feng et al., 2018; Wang et al., 2018; Yan et al., 2016; 64 
McEwan et al., 2014). In addition to improving the distribution and sono-chemical activity, the 65 
existence of a particle in a liquid promotes the formation of a cavitation bubble because of its surface 66 
roughness (Serpe et al., 2012). As another related technology, liposome preparations that release 67 
temperature-sensitive drugs following HIFU irradiation are being examined (Boissenot et al., 2016).  68 
NC-6300 is an EPI-conjugated polyethylene glycol polyaspartate block copolymer. The 69 
conjugates form a micellar structure in aqueous media and exhibit the unique feature of pH-70 
dependent drug release. Approximately 80% of EPI was found to be released within 1 h at pH 3 71 
(Harada et al., 2011). This drug delivery system carrier has been confirmed to be safe based on the 72 
results of a phase 1 clinical trial (Mukai et al., 2017). 73 
Trigger-pulsed HIFU (TP-HIFU) is a programmed sequence consisting of two ultrasound 74 
waves. One is a high-intensity short duration pulse and the other is moderate-intensity long 75 
sustaining wave (Iwasaki et al., 2018; Yoshizawa et al., 2016). TP-HIFU irradiation accelerates the 76 
generation of microbubble clouds and thermal coagulation (Umemura et al., 2013). 77 
We found that the combinatory use of NC-6300 and TP-HIFU irradiation was much more 78 
effective than each single therapy (Maeda et al., 2017). We also conducted clinical safety tests for 79 
TP-HIFU and NC-6300 in pet dogs and confirmed the superior safety of this method. 80 
Despite this progress in practical application, the mechanism of the combination effect and 81 
functional significance of the drug-polymer conjugate is unclear. In this study, we examined the 82 
effect of the combination of TP-HIFU and NC-6300 from the perspective of ROS generation and 83 
changes in drug characteristics. 84 
2. Materials and Methods 85 
2.1. Reagents 86 
NC-6300 was obtained from Nano Carrier Co., Ltd. (with material transfer agreement) and 87 
diluted in Dulbecco's phosphate-buffered saline (DPBS) to prepare a stock solution (EPI 88 
concentration of 2 mM). EPI, distilled water, superoxide dismutase, RPMI 1640 medium, and 89 
accutase were from Nacalai Tesque (Kyoto, Japan). DPBS, iron(II) FeSO4, H2O2, xanthine, and 90 
xanthine oxidase were from Fujifilm Wako Pure Chemical (Osaka, Japan). Fetal bovine serum was 91 
from Gibco (Grand Island, NY, USA). Penicillin-streptomycin solution was from Sigma (St. Louis, 92 
MO, USA). Hydroxy phenyl fluorescein (HPF) was from Goryo Chemical (Sapporo, Japan), and Cell 93 
Counting Kit-8 (CCK-8) and WST-1 were from Dojindo Laboratories (Kumamoto, Japan). The 94 
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Annexin V fluorescein isothiocyanate (FITC)-propidium iodide (PI) kit was from Medical & 95 
Biological Laboratories (Nagoya, Japan). 96 
2.2. Cell lines 97 
Human pancreas adenocarcinoma (BxPC-3) cells were obtained from the American Type 98 
Culture Collection (Manassas, VA, USA) and human peripheral blood promyeloblast (HL-60) cells 99 
were from the Japanese Collection of Research Bioresources Cell Bank. The cells were cultured in 100 
RPMI-1640 medium containing 10% fetal bovine serum and penicillin-streptomycin at 37°C and 5% 101 
CO2 in an incubator. 102 
2.3. HIFU irradiation 103 
The in vitro HIFU system was constructed as shown in Figure 1. The transducer was designed 104 
using a lead zirconate titanate ceramic element (resonant frequency 1.09 MHz, focus distance from 105 
transducer 75 mm) (Abe et al., 2014; Yoshizawa et al., 2016; Maeda et al., 2017). The input signal 106 
was amplified with an amplifier (A300, Electronics & Innovation, Rochester, NY, USA) through the 107 
transducer, followed by the generation of the sequence by the function generator (WF1974, NF 108 
Corporation, Yokohama, Japan). The HIFU conditions (trigger sequence and duration of irradiation) 109 
were controlled with original software. The ultrasound intensity (spatial peak temporal average 110 
intensity; ISPTA, W/cm
2) was measured using a needle-type hydrophone (HPM05, Eastek, Lake 111 
Zurich, IL, USA). TP-HIFU is a programmed wave mixture of a short-duration high-intensity 112 
triggering pulse (2000 W/cm2, 0.02 ms) followed by a heating wave (10–1000 W/cm2). N-HIFU was 113 
single heating wave irradiation (100 W/cm2) without the triggering pulse. The output energy of TP-114 
HIFU at an ultrasound intensity of 100W/cm2 was 10 W. 115 
All irradiation experiments were conducted in a water bath, which was filled with degassed 116 
circulating water (DEGASi High Flow, Biotec, Onsala, Sweden). The water temperature and 117 
dissolved oxygen concentration were maintained at 25 ± 2°C and <3 mg/mL, respectively.  118 
(Figure 1) 119 
The sample container for HIFU irradiation was changed as was necessary. Because plastic 120 
containers are easily deformed by high temperatures and long-duration irradiation, glass test tubes 121 
were used. For short-duration irradiation, 48- and 96-well plates were used to process multiple 122 
samples in one experiment.  123 
2.4. Experiment on degradation stability and release of EPI  124 
The drug was dissolved in DPBS was irradiated with HIFU. Next, the drug concentration was 125 
measured using high-performance liquid chromatography as previously described for NC-6300 126 
(Harada et al., 2011), with some modifications required for the laboratory conditions.  127 
2.5. Cytotoxicity test  128 
BxPC-3 cells were treated with accutase and detached from the plate at 37°C for 15 min. The 129 
detached cells were collected using centrifugation and diluted to 1 × 105 cells/mL. An aliquot of the 130 
sample (0.34 mL) was added to each well of the 96-well plate. The HIFU irradiation group was 131 
placed in the water bath and HIFU irradiation was performed. During the experiment, the 132 
temperature of the water bath was maintained at 25 ± 2°C. HIFU-irradiated samples were dispensed 133 
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at 0.1 mL into a 96-well microplate and cultured for the specified duration at 37°C and 5% CO2 in an 134 
incubator. After cell culture, 10 μL of CCK-8 was added and incubated for an additional 4 h at 37°C. 135 
The cell number was measured using a microplate reader (Infinite M1000 PRO, Tecan, Männedorf, 136 
Switzerland) at a wavelength of 438 nm. Cell viability was calculated using untreated cells as a 137 
control. 138 
2.6. Hydroxyl radical detection assay 139 
To detect hydroxyl radicals, fluorescence was measured using HPF. HPF was added to the 140 
sample solution at a final concentration of 0.025 mM. The sample solution was irradiated with HIFU 141 
after dispersion into a 48-well microplate (1.3 mL). The sample was dispensed into a 96-well plate 142 
for fluorescence intensity measurement. The fluorescence of the decomposed substance (HPF to 143 
fluorescein, ex 490 nm, em 515 nm) was measured in a microplate-reader (Infinite M1000 PRO). 144 
Three samples were included in each group, and the average value and standard deviation of the 145 
fluorescence changes were calculated. 146 
2.7. Super oxide detection assay 147 
To measure superoxide anions, the WST-1 method was used (Ukeda et al., 1999). WST-1 was 148 
added to DPBS at a final concentration of 0.2 mM, and then NC-6300 or EPI was added to the 48-149 
well microplate (1.3 mL) and TP-HIFU irradiation was performed (100 W/cm2, 0.5–3 min) at 25°C. 150 
The absorbance at a wavelength of 438 nm was measured using a UV-VIS-near infrared 151 
spectrophotometer (V-670DS, JASCO, Oklahoma City, OK, USA). Three samples were evaluated 152 
for each group, and the average value and standard deviation of absorbance changes were calculated 153 
before and after HIFU irradiation. 154 
2.8. Flow cytometer analysis 155 
The cellular accumulation of annexin V-FITC and PI was monitored using flow cytometry to 156 
detect changes in the membrane structure caused by ROS. HL-60 cells were cultured in RPMI-1640 157 
medium containing 10% fetal bovine serum and penicillin-streptomycin, and diluted to 1 × 105 158 
cells/mL, and hydroxyl radicals or superoxide anions were generated by the Fenton reaction or 159 
xanthine/xanthine oxidase reaction. In the Fenton reaction, H2O2 solution and FeSO4 solution were 160 
added to a final concentration of 0.005–0.02 mM. In the xanthine/xanthine oxidase reaction, xanthine 161 
and xanthine oxidase were added to final concentrations of 0.005–0.02 mM and 40 mU/mL, 162 
respectively. The reaction was carried out at 37°C and 5% CO2 in an incubator. After incubation for 163 
6 h, annexin-FITC and PI were added according to the manufacturer's instructions and the 164 
luminescence of FITC and PI was monitored with a flow cytometer (LSR Fortessa X-20, BD 165 
Biosciences, Franklin Lakes, NJ, USA) and analyzed using FlowJo v10 software (FlowJo LLC, 166 
Ashland, OR, USA).  167 
Statistical analysis was carried out by using JMP software ver.13.0.0 (SAS Institute, Cary, NC, 168 
USA).  169 
3. Results 170 
We evaluated the effect of TP-HIFU irradiation and compared the amounts of hydroxyl radicals 171 
generated by N-HIFU and TP-HIFU. TP-HIFU generated more hydroxyl radicals even with short-172 
duration irradiation compared to N-HIFU. Hydroxyl radical levels also increased as the HIFU 173 
intensity increased. 174 
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The cytoreductive effect of TP-HIFU was examined using BxPC-3 cells. The cells were 175 
irradiated with TP-HIFU or N-HIFU after detachment using accutase treatment. After 48 h of 176 
incubation, the survival of adherent cells significantly differed between the TP-HIFU and N-HIFU 177 
treatment groups.  178 
 Based on these results, TP-HIFU is a useful method for generating cavitation and cell killing 179 
effects after short-duration irradiation. 180 
(Figure 2) 181 
To confirm the stability of EPI against TP-HIFU, the change in the concentration of EPI upon 182 
TP-HIFU irradiation was measured. EPI showed slight decrease in concentration by TP-HIFU 183 
irradiation. However, EPI degradation was suppressed when NC-6300 was irradiated. 184 
Because hydroxyl radicals may be related to EPI degradation upon HIFU irradiation, we 185 
examined the change in the concentration of EPI by hydroxyl radical addition using the Fenton 186 
reaction. The Fenton reaction is a source of hydroxyl radicals produced by the mixing of iron ion and 187 
H2O2. The EPI concentration was decreased by the generation of hydroxyl radicals. However, NC-188 
6300 was relatively stable after the generation of hydroxyl radicals. 189 
(Figure 3) 190 
To investigate the potency of NC-6300 as a sonosensitizer, we examined the detection of 191 
superoxide anion after HIFU irradiation. Because we could not detect superoxide anion using the 192 
electron spin resonance method, we used the spectroscopic method as previously reported (Ukeda et 193 
al., 1999). 194 
We measured the amount of superoxide anion generated by TP-HIFU irradiation using a UV-195 
VIS-near infrared spectrophotometer. As a result, a concentration-dependent increase in superoxide 196 
anion was observed when NC-6300 was irradiated by TP-HIFU. The TP-HIFU irradiation to NC-197 
6300 without WST-1, the superoxide indicator reagent, showed no absorbance change. The amount 198 
of superoxide reached a maximum level within 1 min of irradiation under this experimental 199 
condition. Moreover, N-6300 showed a superior ability to generate superoxide anion than did EPI. 200 
Addition of superoxide dismutase suppressed the absorbance change after TP-HIFU irradiation. The 201 
generated amount of superoxide anion was estimated to be in the μM range compared with the 202 
concentration of xanthine in the xanthine/xanthine oxidase reaction. 203 
(Figure 4) 204 
To investigate the extracellular function of ROS at the estimated level after TP-HIFU 205 
irradiation, we monitored the apoptosis-related changes in the cells using flow cytometry. HL-60 206 
cells were incubated following addition of hydroxyl radicals or superoxide anions using the Fenton 207 
reaction or xanthine/xanthine oxidase reaction with or without NC-6300. After 6 h of incubation, 208 
FITC- and PI-positive cells were increased after adding both hydroxyl radicals and superoxide 209 
anions. This change was accelerated by adding NC-6300 (5 μM), which was not observed after 210 
adding NC-6300 alone.  211 
(Figure 5) 212 
4. Discussion 213 
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To investigate the mechanism of the antitumor effects of NC-6300 and TP-HIFU 214 
demonstrated previously (Maeda et al., 2017), we evaluated the function of TP-HIFU. We found that 215 
hydroxyl radical generation was promoted by TP-HIFU irradiation (Figure 2(A)). We assume that the 216 
increase in cavitation bubbles by TP-HIFU increases the production of hydroxyl radicals after 217 
sonolysis (Misik et al., 2000). It has been reported that 8–15 μM of hydroxyl radicals were generated 218 
by sonolysis under the irradiation conditions of 30 W, 1,650 kHz, and 30 and 60 s (Nakamura et al., 219 
2011) In contrast, the output energy of TP-HIFU (Figure 2 (A)) was one-third (10 W) that in the 220 
aforementioned study and the same level of hydroxyl radicals were obtained. The amount of 221 
hydroxyl radicals increased with increasing irradiation intensity, even with short-duration irradiation, 222 
suggesting that higher hydroxyl radical generation occurs when the HIFU intensity is increased. 223 
These results indicate that TP-HIFU irradiation produces more hydroxyl radicals in a short duration 224 
and the amount of ROS will be >20 μM under clinical conditions. 225 
Additionally, higher cytoreductivity was observed with the application of TR-HIFU 226 
irradiation (Figure 2(B)). Although the triggering pulse in TP-HIFU is 2000 kw/cm2, the duration is 227 
very short (0.02 ms/cycle, duty 0.2%). Thus, the total output energy is nearly the same as that of N-228 
HIFU which produces only a heating wave. In the preliminary experiment, the temperature of the 229 
microplate well was not increased beyond 35°C throughout irradiation and was within the non-230 
thermal level. Despite these conditions, the difference between TP-HIFU and N-HIFU was clearly 231 
noticeable. To clarify the involvement of hydroxyl radicals in cytotoxicity, we carried out an 232 
additional experiment with 1W (10W/cm2) of TP-HIFU irradiation and a hydroxyl radical scavenger. 233 
We confirmed cytotoxicity at 1W, and the effect was suppressed after addition of 2 mM mannitol or 234 
histidine (Figure S1). 235 
The results of EPI degradation by strong TP-HIFU irradiation and similar results obtained 236 
from Fenton reaction suggest that EPI degradation by TP-HIFU occurred mainly because of hydroxyl 237 
radicals. In contrast, NC-6300 suppressed the degradation of EPI (Figure 3). This may be because 238 
EPI localization at the inner core and surrounding hydrophilic moiety created by the PEG-polyamino 239 
acid polymer blocked hydroxyl radical attack EPI (Figure 6). It is unclear whether other drugs are 240 
protected in a similar manner, and further experiments are necessary.  241 
EPI was not released from NC-6300 even at high-power irradiation (data not shown). The 242 
results indicate that the hydrazone bond which conjugates the EPI and polymer was not cleaved by 243 
TP-HIFU irradiation even at a high energy. No significant change was observed in the particle size in 244 
the nanoparticles after HIFU irradiation (data not shown). These results indicate that cavitation 245 
generated under the current conditions cannot cleave the conjugates. 246 
In contrast, the generation of superoxide anions increased following addition of NC-6300 247 
(Figure 4). Although EPI itself functioned as a sonosensitizer for generating superoxide anion, NC-248 
6300 generated more superoxide anion than EPI. We assumed that EPI localized in the inner core at 249 
high concentration acted promptly in the ROS generation process (Figure 6). However, the 250 
fundamental mechanism underlying the generation of superoxide radicals from epirubicine is unclear 251 
and warrants further study. 252 
(Figure 6) 253 
ROS function is thought to be the key component of SDT. In this study, we estimated the 254 
levels of hydroxyl radicals and superoxide anions at the laboratory scale. Hydroxyl radicals are 255 
thought to reach up to 20 µM and superoxide anions are estimated to be present at up to one tenth of 256 
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the hydroxyl radicals. The results of flow cytometry suggested that the cells were susceptible to ROS 257 
and that apoptosis-like changes occurred at the outer membrane at 20 μM of hydroxyl radicals and 258 
super oxide anions. The hypothesis that ROS might attack from the extracellular matrix is one of the 259 
possible causes of this combination treatment. NC-6300 is moved from blood vessel to tumor region 260 
by EPR effect and may be first accumulated in the extracellular matrix (Chida et al., 2018). We 261 
assume that some intervention of ROS could occur from extracellular matrix to membrane (Figure 262 
S3). Further studies are necessary to determine the following mechanism after the ROS have attacked 263 
from outside of the cellular membrane.  264 
Furthermore, intracellular ROS levels were not determined in this study. Temporal increases 265 
in intracellular ROS levels were observed after 30 min of ultrasound irradiation to metal-porphyrin 266 
complexes (Giuntini et al., 2018), despite the short (<1 s) lifetime of ROS. Combined use of folate- 267 
polyethylene-glycol decorated gold nanoparticles and ultrasound irradiation shows remarkable 268 
cytotoxicity and ROS production in folate receptor overexpressing cells. However, the effect was 269 
suppressed when the cell uptake of the particles was blocked by co-incubation with excess free folate 270 
(Brazzale et al., 2016). It is also reported that ROS generated by SDT is related to autophagy (Li et 271 
al., 2017; Kou et al., 2017). These findings indicates the possibility of a late-phase effect of ROS 272 
after TP-HIFU irradiation, warranting further experiments.  273 
In addition, we assume that more therapeutic effects are expected in this therapy because we 274 
confirmed cooperative HIFU-derived features (ablation, mechanical destruction, and cavitation), an 275 
anticancer drug, and ROS within the dose that is clinically safe. First, cell destruction by TP-HIFU 276 
was immediately observed (Figure S2, 24 h). Second, the anticancer drug suppressed cell 277 
proliferation to inhibit tumor growth. Finally, induced apoptosis further decreased the cancer cell 278 
population (Figure S2, 72 h). One possible clinical benefit is that the anticancer drug is no longer 279 
necessary for cell reduction because HIFU takes over this function and reduces the dose of drug 280 
required from the levels used for cell killing to that for suppressing cell ‘growth’. Thus, the safety 281 
margin for drug administration should be reevaluated. Chemo-radio therapy is the most widely used 282 
therapy. However, the mechanism of radiotherapy does not provide an immediate effect for physical 283 
reduction (such as in surgery and thermal coagulation).  284 
One of the benefits of using drug delivery system carrier conjugation with anticancer drugs is 285 
improved safety, which leads to improved quality of life. However, additional nonclinical data are 286 
required for each target organ to determine their suitability for treatment with nano-micelles. In some 287 
cases, the drug alone be the best treatment. TP-HIFU irradiation may enhance the accumulation of 288 
micelles in cancer tissues, which requires further analysis. Moreover, a diagnostic technology that 289 
can precisely detect smaller target cancer colonies is required.  290 
It has been reported that various types of cancer-associated cells are localized in the tumor 291 
microenvironment (Junttila et al., 2013). It is thought that there is a specific condition for each 292 
cancer-associated cell according to its differentiation and localization. For example, metastatic cells 293 
which are about to separate from the primary tumor mass and migrate to another location might form 294 
small aggregates or single cells. In contrast, cancer-associated fibroblasts may be in the form of 295 
clumps and attached to the tumor (Hwang et al., 2008), suggesting that ablation is the most efficient 296 
form of irradiation. To cover such various microenvironments, combinations of different effects such 297 
as the treatment described in this study are thought to be useful (Figure S4).  298 
In conclusion, drug-conjugated nano-micelles are more desirable for SDT because of 299 
accelerated ROS production and drug protection from ROS. Combinatorial treatment with NC-6300 300 
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and TP-HIFU is a useful approach for minimally invasive cancer therapy, combining the cooperative 301 
effects of HIFU-derived features, anticancer activity of EPI, and increased ROS generation to 302 
damage cancer cells. 303 
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Figure: 407 
 408 
Figure 1. (A) Schematic of the experimental setup. HIFU condition (trigger sequence and duration of 409 
irradiation) was controlled using original software. The signal generated from the function generator 410 
was amplified and then output to the transducer. (B) Sequence of TP-HIFU. High-intensity triggering 411 
pulse and heating wave were irradiated repeatedly. (C) Structure of NC-6300. 412 
  413 
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 414 
Figure 2. (A) Hydroxyl radical measurement by HPF method. In the Fenton reaction sample, H2O2 415 
solution and FeSO4 solution were both added to HPF solution to final concentration of 5, 10, and 20 416 
μM respectively. The fluorescence intensity of the fluorescein released from HPF by hydroxyl 417 
radicals was measured with a microplate reader (em 490 nm, ex 515 nm). HIFU irradiation groups 418 
were collected for 5 or more irradiation samples and the results are presented as the mean ± standard 419 
deviation. *P＜0.05 non-parametric comparison for each pair by Wilcoxon test. (B) Cell viability 420 
assay of BxPC-3 cell line. Suspension of detached BxPC-3 cells were dispensed into a 96-well 421 
microplate for HIFU irradiation. Viable-cell counting was carried out by CCK-8 method. Each group 422 
was collected for 20 or more irradiation samples and the results are presented as the mean ± standard 423 
deviation. * P＜0.05, ** P<0.01, non-parametric comparison for each pair by Wilcoxon test. 424 
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 426 
Figure 3. (A) EPI degradation test by TP-HIFU irradiation. The sample solution containing NC-6300 427 
or EPI (0.1 mg/mL EPI concentration) was irradiated 10 min by TP-HIFU in test tube made of glass. 428 
Residual amount of EPI was calculated with non-irradiated sample set to 100%. The irradiation 429 
groups were collected as 3 samples and presented as the mean ± standard deviation. (B) EPI 430 
degradation test by Fenton reaction. The sample solution containing NC-6300 or EPI (0.01 mM EPI 431 
concentration) was treated with Fenton reaction in test tube. The residual amount of EPI was 432 
measured by HPLC (n = 2–3) and presented as the mean ± standard deviation. * P＜0.05, ** P < 433 
0.01, comparison for each pair by Turkey-Kramer test.  434 
  435 
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 436 
Figure 4. Measurement of the amount of superoxide anions by UV spectrophotometer. The sample 437 
solution containing 0.2 mM WST-1 and the indicated concentration of NC-6300 or EPI (as EPI 438 
concentration) was irradiated by TP-HIFU. (A) TP-HIFU irradiation to NC-6300 in various 439 
concentration and at different irradiation times. (B) Correlation with xanthine concentration in 440 
xanthine/xanthine oxidase reaction and absorbance change at 438 nm. (C) Comparison of the 441 
generation of superoxide anion with NC-6300 and EPI. Superoxide dismutase was added to confirm 442 
generation of the superoxide anion. The absorbance change was measured at 438 nm and that of non-443 
irradiated sample was subtracted. The irradiation groups were collected as 3 samples and presented as 444 
the mean ± standard deviation. ** P < 0.01, comparison for each pair by Turkey-Kramer test. 445 
  446 
   Function of NC-6300 for SDT  
 
16 
 447 
Figure 5. Flow cytometry analysis of HL-60 cells. The cell suspension was dispensed into test tubes 448 
and hydroxyl radicals (HR) or superoxide anions (SA) were added by Fenton reaction or 449 
xanthine/xanthine oxidase reaction. After 6-h incubation at 37°C, the samples were measured by flow 450 
cytometry. (A) FITC and PI intensity changes were monitored to confirm changes in the cell 451 
membrane upon extracellular addition of ROS and NC-6300. (B) Percentage of the number of FITC- 452 
and PI- double-positive cells (Q2 region). Three samples were collected form each group and the 453 
results are presented as the mean ± standard deviation. ** P < 0.01, comparison for each pair by 454 
Turkey-Kramer test. 455 
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 457 
Figure 6. Scheme of the characteristic function of NC-6300 in SDT. (A) Protective effect from 458 
hydroxyl radical. (B) Promoting effect of superoxide anion. 459 
  460 
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Supplementary Figures 461 
 (A) 462 
 463 
(B)      No scavenger                       Mannitol                               Histidine 464 
   465 
Supplementary Figure S1. Cell viability assay of HL-60 cell line.  466 
(A) The HL-60 cells were diluted to 1× 105 cells/mL. An aliquot of the sample (0.34 mL) was added 467 
to each well of the 96-well plate. The HIFU irradiation group was placed in the water bath and HIFU 468 
irradiation was performed (100W/cm2 (10W), 30sec).  469 
(B) The HL-60 cells were diluted to 2 × 105 cells/mL. An aliquot of the sample (0.34 mL) was added 470 
to each well of the 96-well plate. The HIFU irradiation group was placed in the water bath and HIFU 471 
irradiation was performed (10W/cm2 (1W), 180sec). Man: Mannitol, His: Histidine 472 
HIFU-irradiated samples were dispensed at 0.1 mL into a 96-well microplate and 10 μL of CCK-8 473 
was added and incubated for an additional 4 h at 37°C. The cell number was measured using a 474 
microplate reader (Infinite M1000 PRO, Tecan, Männedorf, Switzerland) at a wavelength of 438 nm, 475 
and cell viability was calculated using untreated cells as a control. Each group was collected for 10 476 
irradiation samples and the results are presented as the mean ± standard deviation. ** P<0.01, non-477 
parametric comparison for each pair by Student’s t-test.  478 
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 480 
 481 
            24hr incubation                                          72hr incubation 482 
  483 
Supplementary Figure S2. Cell viability assay of BxPC-3 cell line.  484 
BxPC-3 cells were treated with accutase and then detached from the plate at 37°C for 15 min. The 485 
detached cells were collected by centrifugation and suspended to the medium. After NC-6300 was 486 
added, the suspension was diluted to 1 × 105 cells/mL. An aliquot of the sample (0.34 mL) was added 487 
to each well of the 96-well plate. The HIFU irradiation group was placed in the water bath and HIFU 488 
irradiation was performed. During the experiment, temperature of the water bath was maintained at 489 
37 ± 2°C. HIFU-irradiated samples were dispensed at 0.1 mL into a 96-well microplate and cultured 490 
for the specified duration (24, 72hr) at 37°C and 5% CO2 in an incubator. After cell culture, 10 μL of 491 
CCK-8 was added and incubated for an additional 4 h at 37°C. The cell number was measured using 492 
a microplate reader and cell viability was calculated using untreated cells as a control. Each group 493 
was collected 9-10 samples and presented as the mean ± standard deviation. 494 
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 496 
 497 
 498 
Supplementary Figure S3. Schematic of the hypothetical mechanism of extracellular ROS 499 
function. 500 
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 503 
Supplementary Figure S4. Schematic of the hypothetical mechanism of TP-HIFU and NC-6300 504 
combination treatment.  505 
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